New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:02 EDTAGN, MAPPAllergan, MAP announce FTC grants early termination of waiting period
Allergan (AGN) and MAP Pharmaceuticals (MAPP) announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to the tender offer for all of the outstanding shares of common stock of MAP by Groundhog Acquisition, a wholly-owned subsidiary of Allergan. As previously announced, on January 31, Purchaser initiated a tender offer to purchase all outstanding shares of common stock of MAP for $25.00 per share, net to the seller in cash, without interest and less any applicable withholding taxes. Completion of the tender offer remains subject to other customary conditions as set forth in the Offer to Purchase filed by Purchaser and Allergan with the U.S. SEC on January 31, including the tender of at least a majority of the outstanding shares of common stock of MAP on a fully diluted basis. The tender offer and withdrawal rights are scheduled to expire at 12:00 midnight, New York City time, on the night of February 28.
News For AGN;MAPP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
January 13, 2015
14:00 EDTAGNActavis says Allergan deal could close as early as Q1, as late as Q2
Subscribe for More Information
07:39 EDTAGNAmerican Academy of Cosmetic Surgery to hold a meeting
Subscribe for More Information
January 12, 2015
09:37 EDTAGNSupreme Court rejects Allergan appeal on generic Latisse, Bloomberg reports
08:09 EDTAGNActavis and Allergan announce early termination of HSR waiting period
Subscribe for More Information
08:07 EDTAGNActavis, Allergan announce early termination of Hart Scott Rodino waiting period
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use